University Of Texas Investment Managment as of Sept. 30, 2017
Portfolio Holdings for University Of Texas Investment Managment
University Of Texas Investment Managment holds 25 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Texas Instruments Incorporated (TXN) | 31.2 | $13M | 145k | 89.64 | |
| Williams Partners | 16.1 | $6.7M | 173k | 38.90 | |
| Vanguard Europe Pacific ETF (VEA) | 7.8 | $3.3M | 75k | 43.40 | |
| Vanguard Mid-Cap Value ETF (VOE) | 6.9 | $2.9M | 27k | 105.65 | |
| Vanguard S&p 500 Etf idx (VOO) | 6.9 | $2.9M | 12k | 230.76 | |
| Aeglea Biotherapeutics | 6.2 | $2.6M | 525k | 4.93 | |
| Vanguard Emerging Markets ETF (VWO) | 6.1 | $2.5M | 58k | 43.57 | |
| Bio-path Holdings | 3.3 | $1.4M | 3.8M | 0.36 | |
| Vanguard Energy ETF (VDE) | 2.6 | $1.1M | 12k | 93.54 | |
| General Moly Inc Com Stk | 2.6 | $1.1M | 2.9M | 0.37 | |
| Miragen Therapeutics | 2.3 | $965k | 106k | 9.15 | |
| Vanguard REIT ETF (VNQ) | 2.0 | $829k | 10k | 83.08 | |
| Apollo Endosurgery | 1.7 | $722k | 154k | 4.68 | |
| Lexicon Pharmaceuticals (LXRX) | 1.1 | $439k | 36k | 12.29 | |
| Plx Pharma | 1.0 | $403k | 63k | 6.43 | |
| Comerica Incorporated (CMA) | 0.8 | $343k | 4.5k | 76.05 | |
| Invesco (IVZ) | 0.5 | $207k | 5.9k | 35.08 | |
| Reata Pharmaceuticals Inc Cl A | 0.4 | $166k | 5.3k | 31.19 | |
| Fibrogen (FGEN) | 0.1 | $61k | 1.1k | 53.84 | |
| Chimera Investment Corp etf | 0.1 | $57k | 3.0k | 19.00 | |
| International Seaways (INSW) | 0.1 | $59k | 3.0k | 19.67 | |
| iShares Russell Midcap Growth Idx. (IWP) | 0.1 | $25k | 224.00 | 111.61 | |
| Portland General Electric Company (POR) | 0.0 | $5.0k | 118.00 | 42.37 | |
| Boeing Company (BA) | 0.0 | $2.0k | 6.00 | 333.33 | |
| Pepsi (PEP) | 0.0 | $2.0k | 20.00 | 100.00 |
